Tunicamycin inhibits colon carcinoma growth and aggressiveness via modulation of the ERK-JNK-mediated AKT/mTOR signaling pathway.
about
Tunicamycin inhibits colon carcinoma growth and aggressiveness via modulation of the ERK-JNK-mediated AKT/mTOR signaling pathway.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Tunicamycin inhibits colon car ...... ed AKT/mTOR signaling pathway.
@en
Tunicamycin inhibits colon car ...... ed AKT/mTOR signaling pathway.
@nl
type
label
Tunicamycin inhibits colon car ...... ed AKT/mTOR signaling pathway.
@en
Tunicamycin inhibits colon car ...... ed AKT/mTOR signaling pathway.
@nl
prefLabel
Tunicamycin inhibits colon car ...... ed AKT/mTOR signaling pathway.
@en
Tunicamycin inhibits colon car ...... ed AKT/mTOR signaling pathway.
@nl
P2093
P2860
P356
P1476
Tunicamycin inhibits colon car ...... ed AKT/mTOR signaling pathway.
@en
P2093
P2860
P304
P356
10.3892/MMR.2018.8444
P577
2018-01-17T00:00:00Z